ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
HP |
HP: Haptoglobin precursor [Contains: Haptoglobin alpha chain; Haptoglobin beta c |
3.112 |
Evidence |
|
APCS |
APCS, PTX2: Serum amyloid P-component precursor |
HPN |
HPN, TMPRSS1: Serine protease hepsin |
3.112 |
Evidence |
|
HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
3.112 |
Evidence |
|
VTN |
VTN: Vitronectin precursor |
ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
3.112 |
Evidence |
|
F12 |
F12: Coagulation factor XII precursor |
ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
3.112 |
Evidence |
|
CD33 |
CD33, SIGLEC3: Myeloid cell surface antigen CD33 precursor |
FGL2 |
FGL2: Fibroleukin precursor |
3.112 |
Evidence |
|
CD7 |
CD7: T-cell antigen CD7 precursor |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
3.112 |
Evidence |
|
AMBP |
AMBP, HCP, ITIL: AMBP protein precursor [Contains: Alpha-1-microglobulin |
HPN |
HPN, TMPRSS1: Serine protease hepsin |
3.112 |
Evidence |
|
CSPG2 |
IPI00009802 |
CD33 |
CD33, SIGLEC3: Myeloid cell surface antigen CD33 precursor |
3.112 |
Evidence |
|
HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
3.112 |
Evidence |
|
HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
3.112 |
Evidence |
|
FPR1 |
FPR1: fMet-Leu-Phe receptor |
RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
3.112 |
Evidence |
|
CD7 |
CD7: T-cell antigen CD7 precursor |
XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
3.112 |
Evidence |
|
HPX |
HPX: Hemopexin precursor |
HPN |
HPN, TMPRSS1: Serine protease hepsin |
3.112 |
Evidence |
|
XPO1 |
XPO1, CRM1: Exportin-1 |
RBMX |
RBMX, HNRPG, RBMXP1: Heterogeneous nuclear ribonucleoprotein G |
3.112 |
Evidence |
|
HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
3.112 |
Evidence |
|
HPN |
HPN, TMPRSS1: Serine protease hepsin |
HP |
HP: Haptoglobin precursor [Contains: Haptoglobin alpha chain; Haptoglobin beta c |
3.112 |
Evidence |
|
HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
VAV1 |
VAV1, VAV: Proto-oncogene vav |
3.112 |
Evidence |
|
RHOA |
RHOA, ARH12, ARHA, RHO12: Transforming protein RhoA precursor |
GRIN2A |
GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor |
3.112 |
Evidence |
|
CD3G |
CD3G, T3G: T-cell surface glycoprotein CD3 gamma chain precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
3.112 |
Evidence |
|
HPX |
HPX: Hemopexin precursor |
ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
3.112 |
Evidence |
|
TLR2 |
TLR2, TIL4: Toll-like receptor 2 precursor |
CSPG2 |
IPI00009802 |
3.112 |
Evidence |
|
AREG |
AREG, SDGF: Amphiregulin precursor |
COL17A1 |
COL17A1, BP180, BPAG2: Collagen alpha-1(XVII) chain |
3.112 |
Evidence |
|
CD2 |
CD2, SRBC: T-cell surface antigen CD2 precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
3.112 |
Evidence |
O
|
HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
3.112 |
Evidence |
|